Health
Study reveals new mutations that make cancer resistant to KRAS-targeted therapies – News-Medical.Net
A gene called KRAS is one of the most commonly mutated genes in all human cancers, and targeted drugs that inhibit the protein expressed by mutated KRAS have shown…
A gene called KRAS is one of the most commonly mutated genes in all human cancers, and targeted drugs that inhibit the protein expressed by mutated KRAS have shown promising results in clinical trials, with potential approvals by the U.S. Food and Drug Administration anticipated later this year.
Unfortunately, cancer cells often develop additional mutations that make them resistant to such targeted drugs, resulting in disease relapse. Now researchers led by a team at Massachusetts General Hospital…
-
Noosa News20 hours agoDog owners warned: $834 fine for pets not under control
-
Noosa News22 hours agoPharmacist’s stolen image used in ‘dangerous’ deepfake adverts for weight loss drug
-
Noosa News20 hours agoVarroa mite has been found in South Australia, what impact will it have?
-
Noosa News23 hours agoBrisbane news LIVE updates: Billionaire Clive Palmer’s super yacht docks ahead of Riverfire | Riverfire flyover rehearsal times